Ignite Creation Date:
2025-12-24 @ 10:44 PM
Ignite Modification Date:
2026-02-23 @ 12:20 PM
Study NCT ID:
NCT01158235
Status:
COMPLETED
Last Update Posted:
2011-06-08
First Post:
2010-07-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase I/IIa Study to Evaluate the Safety, Tolerability and Efficacy of Topical LTX-109 in Subjects Nasally Colonized With Methicillin-resistant/-Sensitive Staphylococcus Aureus (MRSA/MSSA)
Sponsor:
Lytix Biopharma AS
Organization: